Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "general transcription factor IIA, 1-like pseudogene" (ENSG00000260184) is a **pseudogene** related in sequence to the gene encoding General transcription factor IIA subunit 1 (GTF2A1). Pseudogenes are segments of DNA that resemble genes but are nonfunctional due to mutations or lack of required regulatory elements. While some pseudogenes can have regulatory effects on the expression of their corresponding protein-coding genes via RNA or chromatin-based mechanisms, this entity does not encode a functional protein and is not a direct therapeutic target. There is no evidence of disease causality, druggability, or clinical biomarker utility for this pseudogene. It exists as a genomic element often used for evolutionary or transcriptional regulation studies but not for active drug discovery or therapeutic intervention[1][7].\n\n**Note:**\n- The “like pseudogene” refers explicitly to a nonfunctional sequence, separating it from functional GTF2A1 or GTF2A1-like factors which are active in the RNA polymerase II transcription pre-initiation complex[3][5].\n- There is no reason to treat this pseudogene as a viable receptor, enzyme, or transporter.\n- No drugs or mechanisms of action are associated with this pseudogene, and it does not have safety concerns or biomarker status in clinical practice.\n\nIf you need information about the functional GTF2A1 (General transcription factor IIA subunit 1), that is a distinct entity with roles in eukaryotic transcription regulation[3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIA subunit 1-like pseudogene.